Journal of Hematology And Oncology Research

ISSN: 2372-6601

JHOR

Ongoing Special Issue
 
Special Issue On -  Advances in Non-Hodgkin Lymphomas
 
Special issue By - Zilu Zhu
 
This special issue calls for original papers with important and novel contributions related to –“ Diffuse Large B-Cell Lymphoma (DLBCL)”
 

Topics of interests include

  • Markers
  • Epidemiology
  • Genetics
  • Drugs
  • Cancer therapy
  • Cancer Care
  • Case reports
  • Surgery
  • Radiology
  • Pathology
  • Imaging
  • Psychosocial
  • Quality of life
  • Risk factors

 

We look for high quality publications on - "Advances in Non-Hodgkin Lymphoma.".

Reviews which include the comparative view, Original research papers as well as short communications and letters on new developments and applications are welcome and are to be written in Standard English. Formatting of manuscript with headings and Sub headings is necessary and views are to be presented clearly. New approaches are mainly in interest.


Metrics:

  • Last Date of Submissions: Will be updated soon
  • Acceptance period:
    • 1st round – 1 month
    • 2nd round – 3 weeks
    • 3rd round – 2 weeks
    • 4th round – 1 week
  • Last Date of Publication: Will be updated soon
  • People involved: Dr. Zilu Zhu - Editor

 

Dr. Zilu Zhu

Editor

 


The importance and need for this special issue:

The emerging challenges and solutions provided by Modern methods are extremely interesting and are of great hope for the future.  This platform brings forth the outstanding research information in the specified field which helps researchers to have a perfect source specifically designed for research on "Diffuse Large B-Cell Lymphoma (DLBCL)" with much emphasis on immunity and cure

This resource not only affects the way the trending research is evolving, but also creates tremendous new support for the now working researchers to put forth their work at a worthy and specifically targeted readership for the desired proper usage of the knowledge dissipated by you.

This research area has many new challenges in the future and many challenges still remain to be resolved, and we hope that this issue will help to open new horizons for research on Diffuse Large B-Cell Lymphoma (DLBCL)